IRIS
DE MARCHI, Fabiola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.910
EU - Europa 3.719
AS - Asia 2.978
SA - Sud America 381
Continente sconosciuto - Info sul continente non disponibili 202
AF - Africa 184
OC - Oceania 4
Totale 11.378
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.735
RU - Federazione Russa 1.130
SG - Singapore 1.105
IT - Italia 658
IE - Irlanda 621
CN - Cina 554
HK - Hong Kong 368
VN - Vietnam 361
DE - Germania 353
BR - Brasile 277
SE - Svezia 248
FR - Francia 180
BD - Bangladesh 152
BJ - Benin 115
GB - Regno Unito 106
KR - Corea 99
UA - Ucraina 94
IN - India 92
CA - Canada 89
FI - Finlandia 53
JP - Giappone 49
MX - Messico 49
PL - Polonia 44
NL - Olanda 43
AR - Argentina 38
TR - Turchia 38
AT - Austria 35
ID - Indonesia 31
ZA - Sudafrica 28
ES - Italia 27
EE - Estonia 21
IR - Iran 21
CZ - Repubblica Ceca 19
IQ - Iraq 18
CL - Cile 15
DK - Danimarca 14
EC - Ecuador 14
LT - Lituania 13
RO - Romania 13
CO - Colombia 12
AE - Emirati Arabi Uniti 11
JO - Giordania 11
BE - Belgio 10
DZ - Algeria 10
JM - Giamaica 9
PK - Pakistan 9
VE - Venezuela 9
MY - Malesia 8
PH - Filippine 8
CH - Svizzera 7
MA - Marocco 7
TN - Tunisia 7
CR - Costa Rica 6
PY - Paraguay 6
DO - Repubblica Dominicana 5
GR - Grecia 5
LB - Libano 5
SA - Arabia Saudita 5
TH - Thailandia 5
UZ - Uzbekistan 5
AU - Australia 4
BO - Bolivia 4
KE - Kenya 4
LV - Lettonia 4
NP - Nepal 4
PE - Perù 4
PT - Portogallo 4
TT - Trinidad e Tobago 4
PA - Panama 3
PS - Palestinian Territory 3
RS - Serbia 3
SY - Repubblica araba siriana 3
AL - Albania 2
AO - Angola 2
AZ - Azerbaigian 2
CI - Costa d'Avorio 2
CY - Cipro 2
HU - Ungheria 2
KZ - Kazakistan 2
NG - Nigeria 2
SI - Slovenia 2
SV - El Salvador 2
UY - Uruguay 2
AG - Antigua e Barbuda 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CM - Camerun 1
DM - Dominica 1
EG - Egitto 1
ET - Etiopia 1
EU - Europa 1
GD - Grenada 1
GT - Guatemala 1
HN - Honduras 1
IL - Israele 1
Totale 11.163
Salva come PNG Salva come JPEG
Città #
Dublin 616
San Jose 514
Singapore 381
Hong Kong 364
Ashburn 334
Council Bluffs 330
Beijing 180
Los Angeles 156
Jacksonville 143
Columbus 139
Moscow 122
Ho Chi Minh City 119
Cotonou 115
Lauterbourg 103
Seoul 92
New York 88
Dallas 72
Santa Clara 72
Munich 70
Chandler 67
Buffalo 64
Hanoi 64
Novara 64
Phoenix 60
Dearborn 58
Rome 56
Turin 54
Milan 52
Orem 50
Mülheim 44
Frankfurt am Main 40
Boardman 35
Lawrence 35
Princeton 35
Falkenstein 32
São Paulo 32
Wilmington 32
Tokyo 31
Warsaw 31
Helsinki 29
Houston 29
Toronto 29
Chennai 28
Denver 27
Montreal 27
Stockholm 27
Mexico City 26
Bremen 24
Brooklyn 24
Nuremberg 24
Strasbourg 24
Amsterdam 23
Chicago 23
Johannesburg 21
Atlanta 20
London 20
Seattle 19
Vienna 19
San Mateo 17
San Francisco 16
The Dalles 16
Boston 15
Brno 15
Da Nang 15
Poplar 15
Vercelli 15
Ankara 14
Hangzhou 14
Piemonte 14
Rio de Janeiro 14
Jakarta 13
Manchester 13
Philadelphia 13
Tianjin 13
Redondo Beach 12
Turku 12
Zanjan 12
Amman 11
Haiphong 11
Queens 11
St Louis 11
Tornaco 11
Brussels 10
Guangzhou 10
Monmouth Junction 10
Mumbai 10
Hillsboro 9
Hải Dương 9
Kocmyrzów 9
Villadossola 9
Dhaka 8
Kocaeli 8
New Delhi 8
Ottawa 8
Santiago 8
Baghdad 7
Borgomanero 7
Charlotte 7
Querétaro 7
Shanghai 7
Totale 5.883
Salva come PNG Salva come JPEG
Nome #
Acetyl-L-carnitine and Amyotrophic Lateral Sclerosis: current evidence and potential use. 265
Retrospective observational study on the use of acetyl-L-carnitine in ALS 197
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene 185
Advances in stem cell therapy for amyotrophic lateral sclerosis 185
Analysis of the GCG Repeat Length in NIPA1 Gene in C9orf72-mediated ALS in a Large Italian ALS Cohort 171
ALS Phenotype Is Influenced by Age, Sex, and Genetics: A Population-Based Study 163
The Epidemiology of Primary Lateral Sclerosis: Results from a Population‐Based Cohort 146
A case of marchiafava bignami disease with frontal cortex involvement and late onset, long-lasting psychiatric symptoms 145
Expanding the genetic spectrum of primary familial brain calcification due to SLC2OA2 mutations: a case series 141
Ptosis and bulbar onset: an unusual phenotype of familial ALS? 133
Characterization of the c9orf72 GC-rich low complexity sequence in two cohorts of Italian and Turkish ALS cases 133
Chronic obstructive pulmonary disease may complicate Alzheimer's disease: a comorbidity problem 130
Intraspinal stem cell transplantation for amyotrophic lateral sclerosis: Ready for efficacy clinical trials? 128
A case of Progressive Non-Fluent Aphasia as onset of Amyotrophic Lateral Sclerosis with FrontoTemporal Dementia 126
A prospective longitudinal study on the microbiota composition in amyotrophic lateral sclerosis 126
Study protocol on the safety and feasibility of a normocaloric ketogenic diet in people with amyotrophic lateral sclerosis 126
Effects of Acetyl-L-Carnitine on Oxidative Stress in Amyotrophic Lateral Sclerosis Patients: Evaluation on Plasma Markers and Members of the Neurovascular Unit 122
Lower Circulating Gas6 Levels Are Associated with Bulbar Phenotype and Faster Disease Progression in Amyotrophic Lateral Sclerosis Patients 122
Neuroinflammatory Pathways in the ALS-FTD Continuum: A Focus on Genetic Variants 121
Headache in immigrant patients: similarities and differences with Italian population 121
Identifying and predicting amyotrophic lateral sclerosis clinical subgroups: a population-based machine-learning study 121
Potential Role of Gut Microbiota in ALS Pathogenesis and Possible Novel Therapeutic Strategies 118
Detection of white matter ultrastructural changes for amyotrophic lateral sclerosis characterization: A diagnostic study from DTI-derived data 118
Effect of RNS60 in amyotrophic lateral sclerosis: a phase II multicentre, randomized, double-blind, placebo-controlled trial 116
The prevention of falls in patients with Parkinson's disease with in-home monitoring using a wearable system: a pilot study protocol 116
The Potential Role of Peripheral Oxidative Stress on the Neurovascular Unit in Amyotrophic Lateral Sclerosis Pathogenesis: A Preliminary Report from Human and In Vitro Evaluations 116
Frontotemporal Dementia Presenting as Gambling Disorder: When a Psychiatric Condition Is the Clue to a Neurodegenerative Disease 114
The length of SNCA Rep1 microsatellite may influence cognitive evolution in Parkinson’s disease 113
Clinical relevance of single-subject brain metabolism patterns in amyotrophic lateral sclerosis mutation carriers 111
Neurological emergency at the COVID-19 pandemic: report from a referral hospital in Eastern Piedmont, Italy 111
Amyotrophic lateral sclerosis regional progression intervals change according to time of involvement of different body regions 107
Phosphatemia is an Independent Prognostic Factor in Amyotrophic Lateral Sclerosis 107
New Insights into the Relationship between Nutrition and Neuroinflammation in Alzheimer's Disease: Preventive and Therapeutic Perspectives 105
null 105
Critical illness neuro-myopathy (CINM) and focal amyotrophy in intensive care unit (ICU) patients with SARS-CoV-2: a case series 104
Adopting Assistive Technologies in Healthcare Processes: A Chatbot for Patients with Amyotrophic Lateral Sclerosis 102
Association of Copresence of Pathogenic Variants Related to Amyotrophic Lateral Sclerosis and Prognosis 101
A pilot trial of RNS60 in amyotrophic lateral sclerosis 101
Exploring the phenotype of Italian patients with ALS with intermediate ATXN2 polyQ repeats 101
Coupling motor evoked potentials and brain [18F]FDG-PET in Amyotrophic Lateral Sclerosis: preliminary findings on disease severity 100
The Need for Biomarkers in the ALS-FTD Spectrum: A Clinical Point of View on the Role of Proteomics 100
C9ORF72 Repeat Expansion Affects the Proteome of Primary Skin Fibroblasts in ALS 100
Circulating GLAST+ EVs are increased in amyotrophic lateral sclerosis 99
Functional status and oral health in patients with amyotrophic lateral sclerosis: A cross-sectional study 99
Occipital Neuralgia in Chiari I Malformation: Two Different Events or Two Different Faces of the Same Event? 99
Depression and risk of Cognitive Dysfunctions in Amyotrophic Lateral Sclerosis 99
Regional spreading of symptoms at diagnosis as a prognostic marker in amyotrophic lateral sclerosis: A population-based study 98
Accelerated early progression of amyotrophic lateral sclerosis over the covid-19 pandemic 95
Potential role of vitamin D levels in amyotrophic lateral sclerosis cognitive impairment 94
Decline of cognitive and behavioral functions in amyotrophic lateral sclerosis: a longitudinal study 92
Telehealth Approach For Amyotrophic Lateral Sclerosis Patients: The experience during COVID-19 pandemic 91
Challenging the boundaries: c9orf72 mutation presenting as Alzheimer's disease 90
Marchiafava-Bignami Disease with frontal cortex involvement and late onset, long-lasting psychiatric symptoms: A case report 90
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology 89
Generation of an induced pluripotent stem cell line, CSSi011-A (6534), from an Amyotrophic lateral sclerosis patient with heterozygous L145F mutation in SOD1 gene 88
Characterization of the p.L145F and p.S135N Mutations in SOD1: Impact on the Metabolism of Fibroblasts Derived from Amyotrophic Lateral Sclerosis Patients 87
Rapamycin treatment for amyotrophic lateral sclerosis: Protocol for a phase II randomized, double-blind, placebo-controlled, multicenter, clinical trial (RAP-ALS trial) 87
Interplay between immunity and amyotrophic lateral sclerosis: Clinical impact 86
Factors associated with the severity of COVID-19 outcomes in people with neuromuscular diseases: Data from the International Neuromuscular COVID-19 Registry 86
Plateaus in amyotrophic lateral sclerosis progression: results from a population-based cohort 86
Investigating the Prognostic Role of Peripheral Inflammatory Markers in Mild Cognitive Impairment 86
Current status and new avenues of stem cell-based preclinical and therapeutic approaches in amyotrophic lateral sclerosis 86
Polymorphisms of dopamine receptor genes and risk of visual hallucinations in Parkinson's patients 86
Immunity in amyotrophic lateral sclerosis: blurred lines between excessive inflammation and inefficient immune responses 84
Shotgun Proteomics Links Proteoglycan-4+ Extracellular Vesicles to Cognitive Protection in Amyotrophic Lateral Sclerosis 84
Profiling cognition and brain metabolism in amyotrophic lateral sclerosis and frontotemporal dementia 84
Effect of mesenchymal stromal cell transplantation on long-term survival in amyotrophic lateral sclerosis 82
Withdrawal of mechanical ventilation in amyotrophic lateral sclerosis patients: a multicenter Italian survey 82
Adjusted cost analysis of video televisits for the care of people with amyotrophic lateral sclerosis 80
Respiratory support in a population-based ALS cohort: Demographic, timing and survival determinants 80
Exploring the phenotypic fingerprints of ANXA11 variants in ALS: a population-based study in an European cohort 80
Identification of Transcriptomic Differences in Induced Pluripotent Stem Cells and Neural Progenitors from Amyotrophic Lateral Sclerosis Patients Carrying Different Mutations: A Pilot Study 80
A case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy after ChAdOx1 nCoV-19 vaccine 80
Telemedicine and technological devices for amyotrophic lateral sclerosis in the era of COVID-19 80
Novel Therapeutic Strategies in Alzheimer's Disease: Pitfalls and Challenges of Anti-Amyloid Therapies and Beyond 79
A Telehealth Intervention for Nutritional Counseling in Amyotrophic Lateral Sclerosis Patients 78
Telehealth in neurodegenerative diseases: Opportunities and challenges for patients and physicians 77
Validation of the DYALS (dysphagia in amyotrophic lateral sclerosis) questionnaire for the evaluation of dysphagia in ALS patients 76
The Role of Tau beyond Alzheimer’s Disease: A Narrative Review 76
Clinical and Metabolic Signature of UNC13A rs12608932 Variant in Amyotrophic Lateral Sclerosis 75
Pharmacotherapy for Amyotrophic Lateral Sclerosis: A Review of Approved and Upcoming Agents 75
Results from Phase I Clinical Trial with Intraspinal Injection of Neural Stem Cells in Amyotrophic Lateral Sclerosis: A Long-Term Outcome 75
Cell therapy in ALS: An update on preclinical and clinical studies 73
Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis 73
The diagnostic and prognostic role of biomarkers for amyotrophic lateral sclerosis 71
Editorial: What's next? Innovative translational markers across the ALS-FTD continuum 69
Do ecological factors influence the clinical presentation of amyotrophic lateral sclerosis? 69
Emerging Trends in the Field of Inflammation and Proteinopathy in ALS/FTD Spectrum Disorder 69
Variability in Clinical Phenotype in TARDBP Mutations: Amyotrophic Lateral Sclerosis Case Description and Literature Review 69
From Mild Cognitive Impairment to Dementia: The Impact of Comorbid Conditions on Disease Conversion 67
Clinical trials in pediatric ALS: a TRICALS feasibility study 67
Patient reported outcomes in ALS: characteristics of the self-entry ALS Functional Rating Scale-revised and the Activities-specific Balance Confidence Scale 67
A case of late-onset OCD developing PLS and FTD 66
What is amyotrophic lateral sclerosis prevalence? 66
Predicting Cognitive Decline in Parkinson's Disease: Can We Ask the Genes? 65
Croplands proximity is associated with amyotrophic lateral sclerosis incidence and age at onset 64
From Biomarkers to Precision Medicine in Neurodegenerative Diseases: Where Are We? 64
Patient reported outcome measures (PROMs) in amyotrophic lateral sclerosis 63
Cortical Excitability as a Prognostic and Phenotypic Stratification Biomarker in Amyotrophic Lateral Sclerosis 62
Effects of acetyl L-carnitine on oxidative stress in Amyotrophic Lateral Sclerosis patients: evaluation on plasma markers and on members of the neurovascular unit 62
Totale 9.999
Salva come PNG Salva come JPEG
Categoria #
all - tutte 54.595
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.595
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022273 0 0 15 26 16 7 2 7 23 16 73 88
2022/20231.230 45 56 40 10 82 88 46 54 667 17 98 27
2023/2024571 50 38 80 29 82 20 76 5 13 5 50 123
2024/20251.855 45 38 125 36 50 196 120 164 339 172 168 402
2025/20265.699 289 206 288 687 669 405 748 881 369 449 417 291
2026/20271.103 294 562 247 0 0 0 0 0 0 0 0 0
Totale 11.378